Ethicon, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1992-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ethicon.com
NeuWave HCC China Study
- Conditions
- Interventions
- First Posted Date
- 2018-12-21
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT03783871
- Locations
- 🇨🇳
The First Affiliated Hospital，Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
🇨🇳Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
SURGICEL® Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding in Adult Subjects
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2021-07-26
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 103
- Registration Number
- NCT03762200
- Locations
- 🇬🇧
Cambridge University Hospitals NHS Trust (Addenbrooke's Hospital), Cambridge, United Kingdom
🇬🇧NHS Lothian (Western General Hospital), Edinburgh, Lothian, United Kingdom
🇧🇪Universitair Ziekenhuis Gent, Gent, Belgium
Ablation Confirmation Study
- Conditions
- Interventions
- First Posted Date
- 2018-11-27
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT03753789
- Locations
- 🇺🇸
Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇺🇸UCLA, Los Angeles, California, United States
NEUWAVE Flexible Probe Study #2
- Conditions
- Interventions
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- Ethicon, Inc.
- Registration Number
- NCT03713099
- Locations
- 🇺🇸
FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung
- Conditions
- Interventions
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2020-12-21
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03603652
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸New York Presbyterian-Weill Cornell Medicine, New York, New York, United States
🇺🇸FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States
Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea
- Conditions
- Interventions
- First Posted Date
- 2018-07-13
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT03586050
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEEDâ„¢
- Conditions
- Interventions
- First Posted Date
- 2018-03-12
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 175
- Registration Number
- NCT03462563
- Locations
- 🇨🇳
Shanghai Jiaotong University School of Medcine, Ruijin Hospital, Shanghai, Shanghai, China
🇨🇳Changhai Hospital, Shanghai, China
🇨🇳First affiliated hospital of zhengzhou university, Zhengzhou, Henan, China
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
- Conditions
- Interventions
- First Posted Date
- 2017-08-21
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT03255174
- Locations
- 🇺🇸
Univesity of Utah, Salt Lake City, Utah, United States
🇺🇸Nemours Children's Specialty Care, Jacksonville, Florida, United States
🇺🇸The Johns Hopkins Hospital, Baltimore, Maryland, United States
A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies
- Conditions
- Interventions
- First Posted Date
- 2017-02-17
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT03056300
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing City, China
The EVICEL® Neurosurgery Phase III Study
- Conditions
- Interventions
- First Posted Date
- 2015-05-29
- Last Posted Date
- 2019-01-10
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 234
- Registration Number
- NCT02457546
- Locations
- 🇺🇸
Clinical Investigation Site #27, Los Angeles, California, United States
🇦🇺Clinical Investigation Site #54, Adelaide, South Australia, Australia
🇺🇸Clinical Investigation Site #22, Indianapolis, Indiana, United States